1. Home
  2. LIXT vs EDTK Comparison

LIXT vs EDTK Comparison

Compare LIXT & EDTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LIXT
  • EDTK
  • Stock Information
  • Founded
  • LIXT 2005
  • EDTK 2013
  • Country
  • LIXT United States
  • EDTK China
  • Employees
  • LIXT N/A
  • EDTK N/A
  • Industry
  • LIXT Biotechnology: Pharmaceutical Preparations
  • EDTK Other Consumer Services
  • Sector
  • LIXT Health Care
  • EDTK Real Estate
  • Exchange
  • LIXT Nasdaq
  • EDTK Nasdaq
  • Market Cap
  • LIXT 20.5M
  • EDTK 16.7M
  • IPO Year
  • LIXT N/A
  • EDTK 2020
  • Fundamental
  • Price
  • LIXT $4.20
  • EDTK $1.06
  • Analyst Decision
  • LIXT
  • EDTK
  • Analyst Count
  • LIXT 0
  • EDTK 0
  • Target Price
  • LIXT N/A
  • EDTK N/A
  • AVG Volume (30 Days)
  • LIXT 120.3K
  • EDTK 3.6K
  • Earning Date
  • LIXT 11-07-2025
  • EDTK 08-08-2025
  • Dividend Yield
  • LIXT N/A
  • EDTK N/A
  • EPS Growth
  • LIXT N/A
  • EDTK N/A
  • EPS
  • LIXT N/A
  • EDTK N/A
  • Revenue
  • LIXT N/A
  • EDTK $893,690.00
  • Revenue This Year
  • LIXT N/A
  • EDTK N/A
  • Revenue Next Year
  • LIXT N/A
  • EDTK N/A
  • P/E Ratio
  • LIXT N/A
  • EDTK N/A
  • Revenue Growth
  • LIXT N/A
  • EDTK N/A
  • 52 Week Low
  • LIXT $0.64
  • EDTK $0.80
  • 52 Week High
  • LIXT $6.26
  • EDTK $1.20
  • Technical
  • Relative Strength Index (RSI)
  • LIXT 41.38
  • EDTK 52.26
  • Support Level
  • LIXT $4.05
  • EDTK $0.97
  • Resistance Level
  • LIXT $4.51
  • EDTK $1.07
  • Average True Range (ATR)
  • LIXT 0.34
  • EDTK 0.03
  • MACD
  • LIXT -0.02
  • EDTK 0.00
  • Stochastic Oscillator
  • LIXT 27.27
  • EDTK 60.00

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

About EDTK Skillful Craftsman Education Technology Limited

Skillful Craftsman Education Technology Ltd provides online education and technology services in China. The services comprises of two aspects - Online vocational training and Virtual simulation experimental training. It covers a wide range of subjects, including mechanics, electronics, auto repair and construction. Majority of its revenues are generated from the People's Republic of China.

Share on Social Networks: